Jul 2014 Flashcards
True/False: for spinal stenosis, the addition of glucocorticoids to lidocaine confers significant short-term benefit compared to lidocaine alone.
False.
Minimal to no benefit.
APOC3 (apolipoprotein C3) gene mutation has what effect?
APOC3 mutations lead to reduction in non-fasting triglycerides levels and is associated with reduced incidence of ischaemic vascular disease, compared to noncarriers of APOC3 mutations.
Which HLA haplotypes are associated with increased risk of coeliac disease in the paediatric population?
HLA DR3-DQ2
HLA DR4-DQ8
With GCA/PMR, disease flares occur during tapering glucocorticoids. How should this be managed?
Flares often respond to 20% increase in glucocorticoid dose.
What proportion of patients with GCS will have involvement of the aorta and it’s major branches?
How should this concern be investigated?
25%
CTA/MRA
What opportunistic infection should be considered in a patient on long-term glucocorticoids for PMR/GCA.
PJP (pneumocytis jerovici pneumonia)
True/False: patients with GCA/PMR have a reduced lifespan.
False.
However, long-term glucocorticoids have yield morbidity from AEs.
For GCA/PMR which two immune response networks have been implicated?
- IL-12 / Th1 / IFN-gamma axis
2. IL6 / Th17 / IL-17 axis
What are the approximate sensitivities and specificities of CRP/ESR in the diagnosis of GCA/PMR?
What percentage of GCA/PMR cases have a normal CRP and ESR?
Sensitivity = 85% (good) Specificity = 30% (poor)
Only 4% (low)
True/False: in the management of GCA/PMR IL-6 levels are superior to CRP levels in guiding management.
False - no evidence for use of IL-6 levels
True/False: routine FDG PET-CT is useful in distinguishing vasculitic and non-vasculitic lesion in GCA/PMR.
False - no recommended for routine use.
In the diagnosis of temporal arteritis which of the following is a suitable alternative to temporal artery biopsy:
A. US
B. MRI
Neither - biopsies are most sensitive to even minor inflammatory changes.
Which glucocorticoid-sparing agents are used in the treatment of GCA/PMR?
None - no agents approved for use in GCA/PMR
Acquired acrodermatitis enteropathica is noted in a 54F with intractable rash refractory to steroid and antifungals with a previous history of bariatric bypass.
What is the treatment?
Cause = reduced zinc levels
Treatment of rash = replace zinc
Patient presents with typical HSV encephalitis with high pre-test probability and clinical suspicion. HSV PCR is however negative. Do you treat it?
Yes - re-test patient whilst commencing on empirical treatment.
True/False: in high risk vascular patients the addition of niacin-laropiprant to statin-bases LDL cholesterol lowering therapy significantly reduces major vascular event.
False.
No benefit and increases risk of many serious AEs (DM, GI, MSK, skin, infection, bleeding)
What is ibrutinib?
What are it’s currently approved indications?
Covalent inhibitor of Bruton’s tyrosine kinase
Indications:
- Mantle cell lymphoma
- CLL (chronic lymphocytic leukaemia) or SLL (small lymphocytic lymphoma)
What is ofatumumab?
Indications?
Monoclonal antibody to CD20.
Indications:
- Haem: Refractory CLL/SLL, NHL (FL/DLBCL)
- Other: RA, refractory MS
What are the AEs of ibrutinib?
nausea, diarrhoea, pyrexia, fatigue
In refractory CLL/SLL which is the preferred agent: ibrutinib or ofatumumab?
Ibrutinib with significantly improved progression-free survival, overall survival and response rate.
What is Lantreotide?
Indications?
Most common AE?
Somatostain analogue.
Indications: treats symtpoms related to hormone hypersecretion in neuroendocrine tumors.
Diarrhoea
How does Lantreotide modify the survival of patients with metastatic enteropancreatic neuroendocrine tumors of grade 1 or 2 compared to placebo.
Prolonged progression-free survival compared to placebo.
However - no change to QoL or overall survival
What is Raltegravir?
New class of antiretroviral HIV drug - integrase inhibitor
Describe in words the 6 step life-cycle of HIV.
Superimpose the potential therapeutic interventions.
- Binding (fusion/entry (CCR5) inhibitors)
- Reverse transcription (NRTIs and NNRTIs)
- Integration (integrase inhibitors)
- Transcription (transcriptor inhibitors)
- Translation
- Viral assembly and maturation (protease inhibitors)